Tulio Rodriguez practices Hematology. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Tulio Rodriguez is a published MD. He has 12 papers published. The most current publication "Safety and efficacy of targeted-dose busulfan and bortezomib as a conditioning regimen for patients with relapsed multiple myeloma undergoing a second autologous blood..." Tulio E. Rodriguez, MD is registered with Medicare.
University of Texas Health Science Center
Sarah Bush Lincoln Health Center| NPI NUMBER | 1831176007 | |
| NPPES Provider LastName | RODRIGUEZ | |
| NPPES Provider FirstName | TULIO | |
| NPPES Provider ZIPCode | 60153 | |
| NPPES Provider State | IL | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 472.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 41.0 | |
| Percent Opioid Claims | 8.69 |
| National Provider Identifier [NPI] | 1831176007 |
| Last Name Of The Provider | RODRIGUEZ |
| First Name Of The Provider | TULIO |
| View All |
|
Dr. Janelle M. Meyer, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Kathy S. Albain, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Shelly Lo, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Yanxia Li, MD |
|
Dr. Urszula A. Sobol, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Shams B. Bakhos, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Malini M. Patel, MD |
|
Dr. Kathrine A. Wentland, MD |